Double blind study with a geriatric drug

Abstract

Clinical tests of Gerigoa Depot were carried out in a double blind study. The experiment was begun on 150 subjects at the same time, so that the climatic factors were uniform. In addition, the basic therapy and diet were kept unchanged. Judgement was based on the changes in intensity of various somatic and psychic symptoms. The therapeutic effect in the trial group differed significantly from that in the placebo group. The tolerance of the preparation was good in all cases.